These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 425758)

  • 41. The model of allergic encephalomyelitis of nonacute, phase course.
    Błaszczyk B; Giełdanowski J; Viljanen MK; Dobryszycka W; Katkiewicz M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):449-58. PubMed ID: 2639641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental encephalomyelitis].
    Invernizzi G; Smeraldi E; Giordano F; Andreola ML
    Folia Allergol (Roma); 1971; 18(4):296-307. PubMed ID: 4940487
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).
    't Hart BA; Massacesi L
    J Neuropathol Exp Neurol; 2009 Apr; 68(4):341-55. PubMed ID: 19337065
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of allergic responses of peripheral blood leukocytes in the pathogenesis of experimental allergic (pertussis) encephalomyelitis].
    Kanchurin AKh; Babakhin AA; Safronova AV
    Biull Eksp Biol Med; 1977 Mar; 83(3):320-4. PubMed ID: 851635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 46. Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.
    Schwerer B; Schuller-Levis GB; Mehta PD; Madrid RE; Wisniewski HM
    Prog Clin Biol Res; 1984; 146():187-92. PubMed ID: 6201889
    [No Abstract]   [Full Text] [Related]  

  • 47. [Changes in the structure and function of brain mitochondria in experimental allergic encephalomyelitis].
    Korin MM; Nedz'ved' GK; Razumovich AN
    Vopr Med Khim; 1970; 16(5):518-24. PubMed ID: 4257161
    [No Abstract]   [Full Text] [Related]  

  • 48. [A study of allergic changes of the lymphoid cells in experimental encephalomyelitis].
    Tsaregorodtseva TM
    Vestn Akad Med Nauk SSSR; 1966; 21(5):81-5. PubMed ID: 5984682
    [No Abstract]   [Full Text] [Related]  

  • 49. [Changes in clinico-immunological indices of experimental allergic encephalomyelitis after treatment with perftoran].
    Zhitnukhin IuL; Litvinenko IV; Bisaga GN; Odinak MM
    Biull Eksp Biol Med; 1997 Mar; 123(3):315-8. PubMed ID: 9162244
    [No Abstract]   [Full Text] [Related]  

  • 50. Epitope and functional specificity of peripheral tolerance induction in experimental autoimmune encephalomyelitis in adult Lewis rats.
    Malotky MK; Pope L; Miller SD
    J Immunol; 1994 Jul; 153(2):841-51. PubMed ID: 7517425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Presentation of myelin basic protein by normal guinea-pig brain endothelial cells and its relevance to experimental allergic encephalomyelitis.
    Wilcox CE; Healey DG; Baker D; Willoughby DA; Turk JL
    Immunology; 1989 Aug; 67(4):435-40. PubMed ID: 2475431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [ALLERGIC ENCEPHALOMYELITIS AND INTERMEDIATE ANTIGENS OF NERVE TISSUES INFECTED WITH VIRUSES].
    ADO AD; KANCHURIN AKh
    Sov Med; 1964 Jan; 27():56-66. PubMed ID: 14164801
    [No Abstract]   [Full Text] [Related]  

  • 53. Complement-fixing antibrain antibodies and allergic encephalomyelitis. II. Further studies concerning their protective role.
    Paterson PY; Jacobs AF; Coia EM
    Ann N Y Acad Sci; 1965 Jun; 124(1):292-8. PubMed ID: 5215763
    [No Abstract]   [Full Text] [Related]  

  • 54. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.
    Leibowitz S; Kennedy L
    Immunology; 1972 May; 22(5):859-69. PubMed ID: 5021707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COMPLEMENT-FIXING ANTIBRAIN ANTIBODIES AND ALLERGIC ENCEPHALOMYELITIS. I. CHARACTERIZATION OF THE ANTIBODIES.
    PATERSON PY; COIA EM; JACOBS AF
    Ann N Y Acad Sci; 1965 Mar; 122():256-65. PubMed ID: 14313483
    [No Abstract]   [Full Text] [Related]  

  • 56. Suppression of allergic encephalomyelitis in rats by means of antibrain serum.
    PATERSON PY; HARWIN SM
    J Exp Med; 1963 May; 117(5):755-74. PubMed ID: 13941827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The problem of circulating antibrain antibodies in experimental allergic encephalomyelitis.
    Saragea M; Vlăduţiu A; Rotaru N; Negru T
    Acta Allergol; 1966; 21(2):139-54. PubMed ID: 5953556
    [No Abstract]   [Full Text] [Related]  

  • 58. From immunoneurology to immunopsychiatry: neuromodulating activity of anti-brain antibodies.
    Janković BD
    Int Rev Neurobiol; 1985; 26():249-314. PubMed ID: 3894271
    [No Abstract]   [Full Text] [Related]  

  • 59. Prothrombin activation by encephalitogenic brain protein.
    Miller KD; Phelan AW; Collins DN
    Exp Mol Pathol; 1966 Dec; 5(6):575-9. PubMed ID: 5958096
    [No Abstract]   [Full Text] [Related]  

  • 60. Agglutinating antibrain antibodies in dogs with experimental allergic encephalomyelitis.
    Saragea M; Negru T; Rotaru N; Vladutiu A
    Experientia; 1965 Apr; 21(4):196-7. PubMed ID: 5844176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.